Cell surface engineering using glycosylphosphatidylinositol anchored tissue inhibitor of matrix metalloproteinase‐1 stimulates cutaneous wound healing |
| |
| Authors: | Roghieh Djafarzadeh PhD Claudius Conrad MD PhD Susan Notohamiprodjo MD Stephanie Hipp Hanno Niess MD Christiane J. Bruns MD PhD Peter J. Nelson PhD |
| |
| Affiliation: | 1. Medical Clinic and Outpatient Clinic IV, University of Munich, , Munich, Germany;2. Department of Surgery, University of Munich, , Munich, Germany;3. Department of Surgery and Harvard Stem Cell Institute, Massachusetts General Hospital, Harvard Medical School, , Boston, Massachusetts |
| |
| Abstract: | The balance between matrix metalloproteinases and their endogenous tissue inhibitors (TIMPs) is an important component in effective wound healing. The biologic action of these proteins is linked in part to the stoichiometry of TIMP/matrix metalloproteinases/surface protein interactions. We recently described the effect of a glycosylphosphatidylinositol (GPI) anchored version of TIMP‐1 on dermal fibroblast biology. Here, cell proliferation assays, in vitro wound healing, electrical wound, and impedance measurements were used to characterize effects of TIMP‐1‐GPI treatment on primary human epidermal keratinocytes. TIMP‐1‐GPI stimulated keratinocyte proliferation, as well as mobilization and migration. In parallel, it suppressed the migration and matrix secretion of dermal myofibroblasts, and reduced their secretion of active TGF‐β1. Topical application of TIMP‐1‐GPI in an in vivo excisional wound model increased the rate of wound healing. The agent positively influenced different aspects of wound healing depending on the cell type studied. TIMP‐1‐GPI counters potential negative effects of overactive myofibroblasts and enhances the mobilization and proliferation of keratinocytes essential for effective wound healing. The application of TIMP‐1‐GPI represents a novel and practical clinical solution for facilitating healing of difficult wounds. |
| |
| Keywords: | |
|
|
